Sheila A. Hunter

1.0k total citations
34 papers, 852 citations indexed

About

Sheila A. Hunter is a scholar working on Pharmacology, Endocrinology, Diabetes and Metabolism and Pathology and Forensic Medicine. According to data from OpenAlex, Sheila A. Hunter has authored 34 papers receiving a total of 852 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pharmacology, 9 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Sheila A. Hunter's work include Cannabis and Cannabinoid Research (23 papers), Alcohol Consumption and Health Effects (6 papers) and Forensic Toxicology and Drug Analysis (6 papers). Sheila A. Hunter is often cited by papers focused on Cannabis and Cannabinoid Research (23 papers), Alcohol Consumption and Health Effects (6 papers) and Forensic Toxicology and Drug Analysis (6 papers). Sheila A. Hunter collaborates with scholars based in United States, Australia and Israel. Sheila A. Hunter's co-authors include Sumner Burstein, I. E. Bush, Robert A. Meigs, Vaughan M. Latham, Charlene A. Audette, Keith M. Hull, Robert B. Zurier, Joan H. Lane, John M. Goldberg and Ronald G. Rossetti and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, The FASEB Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

Sheila A. Hunter

34 papers receiving 817 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sheila A. Hunter United States 19 652 290 149 122 104 34 852
Kent‐Olov Jonsson Sweden 10 625 1.0× 211 0.7× 118 0.8× 137 1.1× 74 0.7× 10 743
Evgueni V. Berdyshev United States 12 643 1.0× 216 0.7× 114 0.8× 130 1.1× 77 0.7× 13 747
Birthe Moesgaard Denmark 12 585 0.9× 236 0.8× 117 0.8× 124 1.0× 86 0.8× 14 711
Jessica P. Alexander United States 6 602 0.9× 206 0.7× 109 0.7× 268 2.2× 107 1.0× 6 934
Takashi Tonegawa Japan 7 570 0.9× 261 0.9× 86 0.6× 87 0.7× 106 1.0× 7 637
Randy J. Krebsbach United States 16 1.2k 1.9× 390 1.3× 187 1.3× 181 1.5× 197 1.9× 18 1.5k
María Gómez‐Cañas Spain 18 801 1.2× 367 1.3× 86 0.6× 277 2.3× 52 0.5× 33 1.1k
Silvano Sanchini United States 9 408 0.6× 144 0.5× 39 0.3× 148 1.2× 77 0.7× 10 545
Matthew W. Elmes United States 10 438 0.7× 187 0.6× 88 0.6× 175 1.4× 33 0.3× 13 676
D. Matthew Walentiny United States 14 519 0.8× 410 1.4× 62 0.4× 159 1.3× 122 1.2× 29 755

Countries citing papers authored by Sheila A. Hunter

Since Specialization
Citations

This map shows the geographic impact of Sheila A. Hunter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheila A. Hunter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheila A. Hunter more than expected).

Fields of papers citing papers by Sheila A. Hunter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheila A. Hunter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheila A. Hunter. The network helps show where Sheila A. Hunter may publish in the future.

Co-authorship network of co-authors of Sheila A. Hunter

This figure shows the co-authorship network connecting the top 25 collaborators of Sheila A. Hunter. A scholar is included among the top collaborators of Sheila A. Hunter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheila A. Hunter. Sheila A. Hunter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zurier, Robert B., Ronald G. Rossetti, Joan H. Lane, et al.. (1998). Dimethylheptyl-THC-11 OIC acid: A nonpsychoactive antiinflammatory agent with a cannabinoid template structure. Arthritis & Rheumatism. 41(1). 163–170. 87 indexed citations
2.
Zurier, Robert B., Ronald G. Rossetti, Joan H. Lane, et al.. (1998). Dimethylheptyl‐THC‐11 OIC acid: A nonpsychoactive antiinflammatory agent with a cannabinoid template structure. Arthritis & Rheumatism. 41(1). 163–170. 7 indexed citations
3.
Hunter, Sheila A. & Sumner Burstein. (1997). Receptor mediation in cannabinoid stimulated arachidonic acid mobilization and anandamide synthesis. Life Sciences. 60(18). 1563–1573. 63 indexed citations
4.
Burstein, Sumner & Sheila A. Hunter. (1995). Stimulation of anandamide biosynthesis in N-18TG2 neuroblastoma cells by δ9-tetrahydrocannabinol (THC). Biochemical Pharmacology. 49(6). 855–858. 19 indexed citations
5.
Burstein, Sumner, et al.. (1994). Phospholipase participation in cannabinoid-induced release of free arachidonic acid. Biochemical Pharmacology. 48(6). 1253–1264. 50 indexed citations
6.
Hunter, Sheila A., Charlene A. Audette, & Sumner Burstein. (1991). Elevation of brain prostaglandin E2 levels in rodents by Δ1-tetrahydrocannabinol. Prostaglandins Leukotrienes and Essential Fatty Acids. 43(3). 185–190. 19 indexed citations
7.
Burstein, Sumner, Charlene A. Audette, Avgui Charalambous, et al.. (1991). Detection of cannabinoid receptors by photoaffinity labelling. Biochemical and Biophysical Research Communications. 176(1). 492–497. 15 indexed citations
8.
Audette, Charlene A., Sumner Burstein, Sharon A. Doyle, & Sheila A. Hunter. (1991). G-protein mediation of cannabinoid-induced phospholipase activation. Pharmacology Biochemistry and Behavior. 40(3). 559–563. 21 indexed citations
9.
Pollak, Raymond, et al.. (1989). Prostaglandin E1 and E2 suppression of in vitro lymphoid responses to alloantigen.. PubMed. 21(5). 3769–70. 1 indexed citations
10.
Burstein, Sumner, et al.. (1986). Prostaglandins and cannabis XV. Comparison of enantiomeric cannabinoids in stimulating prostaglandin synthesis in fibroblasts. Life Sciences. 39(19). 1813–1823. 15 indexed citations
11.
Burstein, Sumner, et al.. (1985). Prostaglandins and cannabis XIV. Tolerance to the stimulatory actions of cannabinoids on arachidonate metabolism.. Journal of Pharmacology and Experimental Therapeutics. 235(1). 87–91. 12 indexed citations
12.
Burstein, Sumner, et al.. (1983). Prostaglandins and cannabis. XII. The effect of cannabinoid structure on the synthesis of prostaglandins by human lung fibroblasts.. Molecular Pharmacology. 23(1). 121–126. 25 indexed citations
13.
Burstein, Sumner, et al.. (1982). Prostaglandins and cannabis—IX. Biochemical Pharmacology. 31(14). 2361–2365. 38 indexed citations
14.
Burstein, Sumner & Sheila A. Hunter. (1981). Prostaglandins and Cannabis—VIII. Elevation of Phospholipase A2 Activity by Cannabinoids in Whole Cells and Subcellular Preparations. The Journal of Clinical Pharmacology. 21(S1). 240S–248S. 35 indexed citations
15.
Hunter, Sheila A., et al.. (1980). The Nature of the Inhibition of Cholesterol Esterase byΔ^1-Tetrahydrocannabinol. Enzyme. 25(2). 87–91. 6 indexed citations
16.
Burstein, Sumner, et al.. (1980). Further studies on the inhibition of Leydig cell testosterone production by cannabinoids. Biochemical Pharmacology. 29(15). 2153–2154. 9 indexed citations
17.
Burstein, Sumner, et al.. (1979). Site of Inhibition of Leydig Cell Testosterone Synthesis by Δ1-Tetrahydrocannabinol. Molecular Pharmacology. 15(3). 633–640. 1 indexed citations
18.
Burstein, Sumner & Sheila A. Hunter. (1978). Prostaglandins and cannabis—VI. Biochemical Pharmacology. 27(8). 1275–1280. 51 indexed citations
19.
Burstein, Sumner, et al.. (1978). Inhibition of cholesterol esterases by Δ1-tetrahydrocannabinol. Life Sciences. 23(9). 979–982. 18 indexed citations
20.
Bush, I. E., Sheila A. Hunter, & Robert A. Meigs. (1968). Metabolism of 11-oxygenated steroids. Metabolism in vitro by preparations of liver. Biochemical Journal. 107(2). 239–258. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kent‐Olov Jonsson Breakdown of academic impact, for papers by Evgueni V. Berdyshev Breakdown of academic impact, for papers by Birthe Moesgaard Breakdown of academic impact, for papers by Jessica P. Alexander Breakdown of academic impact, for papers by Takashi Tonegawa Breakdown of academic impact, for papers by Randy J. Krebsbach Breakdown of academic impact, for papers by María Gómez‐Cañas Breakdown of academic impact, for papers by Silvano Sanchini Breakdown of academic impact, for papers by Matthew W. Elmes Breakdown of academic impact, for papers by D. Matthew Walentiny
Rankless by CCL
2026